Effects of Granulocyte Macrophage Colony-Stimulating Factor Inhibition on the Skin/Nerve Cell Model In Vitro
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Na-Hyun | - |
dc.contributor.author | Jung, Jae-Eun | - |
dc.contributor.author | Lee, Jae-Sun | - |
dc.contributor.author | Jeong, Seong-Ho | - |
dc.contributor.author | Dhong, Eun-Sang | - |
dc.contributor.author | Han, Seung-Kyu | - |
dc.date.accessioned | 2021-08-30T20:19:13Z | - |
dc.date.available | 2021-08-30T20:19:13Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 1049-2275 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/54837 | - |
dc.description.abstract | The present study is based on the concept of neuro-aging and how it may affect surrounding skin cells. It has been shown that many factors play a significant role in skin homeostasis by interfering with various cytokines, either through activation or inhibition. Granulocyte macrophage colony-stimulating factor (GM-CSF) is generally recognized as an inflammatory cytokine, and our previous study has shown its effects on neuronal senescence after ultraviolet (UV) irradiation of skin cells. Following our previous work, this study was performed to investigate the neuroprotective effects of a GM-CSF antagonist, and how it may play an essential role in mediating anti-senescence and anti-inflammatory effects in the keratinocyte/nerve aging model. When human blastoma cells (SH-SY5Y) were treated with 10 ng/ml of GM-CSF, the levels of regulatory RNAs associated with aging, such as matrix metalloproteinase-9 (MMP9), nuclear factor NF-kappa-B p50 subunit (NFKB), inducible nitric oxide synthase (iNOS), and interleukin 1 beta (IL-1 beta) increased, whereas GM-CSF inhibition caused their expression to decrease. A decrease in the antioxidant, glutathione (GSH) was observed after SH-SY5Y cells were treated with GM-CSF. This study confirms that this GM-CSF antagonist may play an important role in neural senescence, where inhibition may be a new target in the skin/nerve aging model. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | GM-CSF | - |
dc.subject | THERAPEUTIC TARGET | - |
dc.subject | SKIN | - |
dc.subject | INFLAMMATION | - |
dc.subject | EXPRESSION | - |
dc.title | Effects of Granulocyte Macrophage Colony-Stimulating Factor Inhibition on the Skin/Nerve Cell Model In Vitro | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jeong, Seong-Ho | - |
dc.contributor.affiliatedAuthor | Dhong, Eun-Sang | - |
dc.identifier.doi | 10.1097/SCS.0000000000006411 | - |
dc.identifier.scopusid | 2-s2.0-85088209736 | - |
dc.identifier.wosid | 000600784100108 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CRANIOFACIAL SURGERY, v.31, no.5, pp.1483 - 1487 | - |
dc.relation.isPartOf | JOURNAL OF CRANIOFACIAL SURGERY | - |
dc.citation.title | JOURNAL OF CRANIOFACIAL SURGERY | - |
dc.citation.volume | 31 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1483 | - |
dc.citation.endPage | 1487 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | GM-CSF | - |
dc.subject.keywordPlus | THERAPEUTIC TARGET | - |
dc.subject.keywordPlus | SKIN | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordAuthor | GM-CSF antagonist | - |
dc.subject.keywordAuthor | nerve cells | - |
dc.subject.keywordAuthor | neuro-aging | - |
dc.subject.keywordAuthor | keratinocytes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.